|
Ann Slee is clinical lead, ePrescribing
programme, at NHS Connecting for Health
Keith Farrar is clinical
lead, ePrescribing,
Computer Sciences Corporation
Don Hughes is director of pharmacy,
Conwy and Denbigshire NHS Trust
Sue Ashwell is chief pharmacist and
assistant director of commissioning, Cambridgeshire Primary Care
Trust
Correspondence
to
ann.slee@nhs.net |
|

|
SUMMARY
Electronic prescribing (ePrescribing) has been heralded as bringing major
benefits to patients by reducing the incidence of medication errors and
improving communication about medicines. It will also support clinical
activity by interacting with knowledge sources and providing decision support
at the point of prescribing or administration
While it is clear that there is much to gain from ePrescribing, there
are also cautionary tales of instances where such systems have actually
increased error rates and have needed to be removed.
The introduction of ePrescribing should be seen as an enabler supporting
the development of new ways of working, not as an all-powerful technology
that dictates how work should be undertaken. It should facilitate and support
change, not require that practice be altered to allow system use.
All too frequently, the implementation of technology fails to deliver benefit
because the system does not meet needs, or has not been viewed as a way
of supporting development. Equally a lack of clinical engagement and leadership
within an organisation and a failure to manage the cultural changes required
may contribute to less than optimal gain from systems.
The introduction of ePrescribing has implications for hospital pharmacy.
This article examines these, looking at the benefits and challenges of
implementing this technology. Issues such as how the introduction of ePrescribing
is likely to alter current medicines management practice in the UK, what
underpinning work will be required and how the profession can avoid falling
into the trap of having practice dictated by technology are considered.
Full text article PDF (80K) |